Knowledge Hub

At Sterling, we are proud of our heritage, strong technical capabilities and compliance credentials but it’s our people and the genuine and passionate way they do business that makes us different.

Sterling manages the most complex API and API intermediate challenges from proof-of-concept to commercial manufacture, as well as Antibody Drug Conjugate (ADC) research and development bioconjugation services.

At Sterling we believe that whilst science can be complex, partnerships should be simple. That is why we have prepared a range of resources to share our team’s research and expertise, and to help you learn more about Sterling and the services we offer.

Filter Content

Knowledge Hub Articles

Sterling Appoints Professor Ian Baxendale to Spearhead Flow Chemistry Development Team

Sterling appoints Stewart Mitchell as site head for its ADC facility

Sterling Pharma Solutions appoints David Topp as Chief Human Resources Officer

Technologies & Services

Service. Passion. Science.